AFP
GH icon

Ausdal Financial Partners’s Guardant Health GH Stock Holding History

Ausdal Financial Partners’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-7,000
Closed -$214K – 654
2024
Q4 		$214K Buy
+7,000
New +$197K 0.02% 534

Other funds holding GH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Ausdal Financial Partners's GH Position: Q1 2025 in Review

Ausdal Financial Partners sold out of Guardant Health (GH) in Q1 2025, closing a stake of 7,000 shares — an estimated $214K sold.

Ausdal Financial Partners first reported a position in GH in Q4 2024 and held it in 1 quarter. The position peaked at $214K in Q4 2024. 342 funds tracked by Wall St. Rank hold GH as of Q1 2025.

  • Ausdal Financial Partners reported no remaining Guardant Health position as of Q1 2025 after selling out during the quarter.
  • Ausdal Financial Partners sold 7,000 Guardant Health shares in Q1 2025, an estimated $214K.
  • Ausdal Financial Partners first reported a position in Guardant Health in Q4 2024 and held it in 1 quarter.
  • Ausdal Financial Partners's Guardant Health position peaked at $214K in Q4 2024.
  • 342 funds tracked by Wall St. Rank held Guardant Health as of Q1 2025.

Based on Ausdal Financial Partners's 13F filing for Q1 2025, filed 15 May 2025.